These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 11405518)
1. IL-4 fails to regulate in vitro beryllium-induced cytokines in berylliosis. Maier LA; Sawyer RT; Tinkle SS; Kittle LA; Barker EA; Balkissoon R; Rose C; Newman LS Eur Respir J; 2001 Mar; 17(3):403-15. PubMed ID: 11405518 [TBL] [Abstract][Full Text] [Related]
2. Cytokine production by bronchoalveolar lavage cells in chronic beryllium disease. Tinkle SS; Schwitters PW; Newman LS Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):969-71. PubMed ID: 8933043 [TBL] [Abstract][Full Text] [Related]
3. Beryllium induces IL-2 and IFN-gamma in berylliosis. Tinkle SS; Kittle LA; Schumacher BA; Newman LS J Immunol; 1997 Jan; 158(1):518-26. PubMed ID: 8977230 [TBL] [Abstract][Full Text] [Related]
4. Partial IL-10 inhibition of the cell-mediated immune response in chronic beryllium disease. Tinkle SS; Kittle LA; Newman LS J Immunol; 1999 Sep; 163(5):2747-53. PubMed ID: 10453017 [TBL] [Abstract][Full Text] [Related]
5. Beryllium-induced tumor necrosis factor-alpha production by CD4+ T cells is mediated by HLA-DP. Sawyer RT; Parsons CE; Fontenot AP; Maier LA; Gillespie MM; Gottschall EB; Silveira L; Newman LS Am J Respir Cell Mol Biol; 2004 Jul; 31(1):122-30. PubMed ID: 14975942 [TBL] [Abstract][Full Text] [Related]
6. HLA-DP-unrestricted TNF-alpha release in beryllium-stimulated peripheral blood mononuclear cells. Amicosante M; Berretta F; Franchi A; Rogliani P; Dotti C; Losi M; Dweik R; Saltini C Eur Respir J; 2002 Nov; 20(5):1174-8. PubMed ID: 12449171 [TBL] [Abstract][Full Text] [Related]
7. Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease. Tinkle SS; Newman LS Am J Respir Crit Care Med; 1997 Dec; 156(6):1884-91. PubMed ID: 9412570 [TBL] [Abstract][Full Text] [Related]
8. Sulfasalazine and mesalamine modulate beryllium-specific lymphocyte proliferation and inflammatory cytokine production. Dobis DR; Sawyer RT; Gillespie MM; Newman LS; Maier LA; Day BJ Am J Respir Cell Mol Biol; 2010 Oct; 43(4):458-64. PubMed ID: 19901345 [TBL] [Abstract][Full Text] [Related]
9. Beryllium-induced TNF-alpha production is transcription-dependent in chronic beryllium disease. Sawyer RT; Fontenot AP; Barnes TA; Parsons CE; Tooker BC; Maier LA; Gillespie MM; Gottschall EB; Silveira L; Hagman J; Newman LS Am J Respir Cell Mol Biol; 2007 Feb; 36(2):191-200. PubMed ID: 16980557 [TBL] [Abstract][Full Text] [Related]
10. 5-Aminosalicylic Acid Modulates the Immune Response in Chronic Beryllium Disease Subjects. Day BJ; Huang J; Barkes BQ; Gillespie M; Li L; Maier LA Lung; 2018 Feb; 196(1):103-114. PubMed ID: 29080069 [TBL] [Abstract][Full Text] [Related]
11. Self-presentation of beryllium by BAL CD4+ T cells: T cell-T cell interactions and their potential role in chronic beryllium disease. Fontenot AP; Edwards DM; Chou YK; Mack DG; LaTocha D; Vandenbark AA; Burrows GG Eur J Immunol; 2006 Apr; 36(4):930-9. PubMed ID: 16552706 [TBL] [Abstract][Full Text] [Related]
12. Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects. Mack DG; Lanham AM; Falta MT; Palmer BE; Maier LA; Fontenot AP Am J Respir Crit Care Med; 2010 Jun; 181(11):1241-9. PubMed ID: 20299529 [TBL] [Abstract][Full Text] [Related]
13. High beryllium-stimulated TNF-alpha is associated with the -308 TNF-alpha promoter polymorphism and with clinical severity in chronic beryllium disease. Maier LA; Sawyer RT; Bauer RA; Kittle LA; Lympany P; McGrath D; Dubois R; Daniloff E; Rose CS; Newman LS Am J Respir Crit Care Med; 2001 Oct; 164(7):1192-9. PubMed ID: 11673208 [TBL] [Abstract][Full Text] [Related]
14. Beryllium-stimulated production of tumor necrosis factor-alpha by a mouse hybrid macrophage cell line. Sawyer RT; Kittle LA; Hamada H; Newman LS; Campbell PA Toxicology; 2000 Mar; 143(3):235-47. PubMed ID: 10755710 [TBL] [Abstract][Full Text] [Related]
16. Beryllium-stimulated neopterin as a diagnostic adjunct in chronic beryllium disease. Maier LA; Kittle LA; Mroz MM; Newman LS Am J Ind Med; 2003 Jun; 43(6):592-601. PubMed ID: 12768609 [TBL] [Abstract][Full Text] [Related]
17. Beryllium-ferritin: lymphocyte proliferation and macrophage apoptosis in chronic beryllium disease. Sawyer RT; Day BJ; Fadok VA; Chiarappa-Zucca M; Maier LA; Fontenot AP; Silveira L; Newman LS Am J Respir Cell Mol Biol; 2004 Oct; 31(4):470-7. PubMed ID: 15256386 [TBL] [Abstract][Full Text] [Related]
18. Expansions of T-cell subsets expressing particular T-cell receptor variable regions in chronic beryllium disease. Fontenot AP; Kotzin BL; Comment CE; Newman LS Am J Respir Cell Mol Biol; 1998 Apr; 18(4):581-9. PubMed ID: 9533947 [TBL] [Abstract][Full Text] [Related]
19. Beryllium increases the CD14(dim)CD16+ subset in the lung of chronic beryllium disease. Li L; Hamzeh N; Gillespie M; Elliott J; Wang J; Gottschall EB; Mroz PM; Maier LA PLoS One; 2015; 10(2):e0117276. PubMed ID: 25689051 [TBL] [Abstract][Full Text] [Related]